← All Sponsors
SPONSOR

Larimar Therapeutics, Inc.

Total Trials
1
Recruiting
1
Phases
Phase 2
Conditions studied: Friedreich Ataxia
NCT06447025 Phase 2
Recruiting

An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia

Friedreich Ataxia
United States View Trial →